| Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer, Carobene A, Guerra E, Locatelli M, Cucchiara V, Briganti A, Aarsand AK et al, 2018, Clin Chim Acta, 486, 185-91 | 6.8 | 42.0 | Males | Healthy (excl pregnant) | Serum |
| Pre-analytical and biological variability of prostatic acid phosphatase and Prostate-Specific Antigen in serum from patients with prostatic pathology , Panteghini M, Pagani F, Bonora R , 1992, Eur J Clin Chem Clin Biochem, 30, 135-9 | 14.0 | | Males | Non-healthy (excl pregnant) | Serum |
| Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer, Mannini D, Maver P, Aiello E, et al, 1988, Urol Res, 16(1), 9-12 | 26.1 | | Males | Non-healthy (excl pregnant) | Serum |
| Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination, Morote J, Raventós CX, Lorente JA et al , 1999, Eur Urol, 36(2), 111-5 | 15.7 | | Males | Non-healthy (excl pregnant) | Serum |
| Physiologic (intraindividual) variation of serum protate-specific antigen in 814 men from a screening population, Komatsu K, Wehner N, Prestigiacomo A et al, 1996, Urology, 47(3), 343-6 | 18.8 | | Males | Healthy (excl pregnant) | Serum |
| Physiologic (intraindividual) variation of serum protate-specific antigen in 814 men from a screening population, Komatsu K, Wehner N, Prestigiacomo A et al, 1996, Urology, 47(3), 343-6 | 20.0 | | Males | Healthy (excl pregnant) | Serum |
| Physiologic (intraindividual) variation of serum protate-specific antigen in 814 men from a screening population, Komatsu K, Wehner N, Prestigiacomo A et al, 1996, Urology, 47(3), 343-6 | 11.9 | | Males | Healthy (excl pregnant) | Serum |
| Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination, Morote J, Raventós CX, Lorente JA et al , 1999, Eur Urol, 36(2), 111-5 | 19.6 | | Males | Non-healthy (excl pregnant) | Serum |
| Prostate-specific antigen: establishment of the reference range for the clinically normal prostate gland and the effect of digital rectal examination, ejaculation, and time on serum concentrations, Glenski WJ, Klee GG, Bergstralh EJ, Oesterling JE. , 1992, Prostate, 21(2), 99-110 | 16.5 | | Males | Healthy (excl pregnant) | Serum |
| Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination, Morote J, Raventós CX, Lorente JA et al , 1999, Eur Urol, 36(2), 111-5 | 13.1 | | Males | Non-healthy (excl pregnant) | Serum |
| Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination, Morote J, Raventós CX, Lorente JA et al , 1999, Eur Urol, 36(2), 111-5 | 15.9 | | Males | Non-healthy (excl pregnant) | Serum |
| Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination, Morote J, Raventós CX, Lorente JA et al , 1999, Eur Urol, 36(2), 111-5 | 15.4 | | Males | Non-healthy (excl pregnant) | Serum |
| Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer, Mannini D, Maver P, Aiello E, et al, 1988, Urol Res, 16(1), 9-12 | 21.5 | | Males | Non-healthy (excl pregnant) | Serum |
| Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation, Bunting PS, DeBoer G, Choo R et al, 2002, Clin Biochem, 35, 471-5 | 21.6 | | Males | Non-healthy (excl pregnant) | Serum |
| Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen, Nixon RG, Lilly JD, Liedtke RJ, Batjer JD, 1997, Arch Pathol Lab Med, 121(4), 385-91 | 5.6 | | Males | Non-healthy (excl pregnant) | Serum |
| Assessment of intra-individual variation in prostate-specific antigen levels in a biennal randomized prostate càncer screening program in Sweden, Bruun L, Becker Ch et al, 2005, Prostate, 65, 216-21 | 12.5 | | Males | Healthy (excl pregnant) | Serum |
| Assessment of intra-individual variation in prostate-specific antigen levels in a biennal randomized prostate càncer screening program in Sweden, Bruun L, Becker Ch et al, 2005, Prostate, 65, 216-21 | 11.4 | | Males | Healthy (excl pregnant) | Serum |
| Biological variation of prostate specific antigen levels In serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients, Nixon RG, Wener MH et al, 1997, J Urol, 157, 2183-90 | 10.1 | | Males | Healthy (excl pregnant) | Serum |
| Biological variation of prostate specific antigen levels In serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients, Nixon RG, Wener MH et al, 1997, J Urol, 157, 2183-90 | 8.8 | | Males | Non-healthy (excl pregnant) | Serum |
| Biological variation of prostate specific antigen levels In serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients, Nixon RG, Wener MH et al, 1997, J Urol, 157, 2183-90 | 11.5 | | Males | Non-healthy (excl pregnant) | Serum |
| Biological variation of prostate specific antigen levels In serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients, Nixon RG, Wener MH et al, 1997, J Urol, 157, 2183-90 | 5.8 | | Males | Non-healthy (excl pregnant) | Serum |
| Biological variation of prostate specific antigen levels In serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients, Nixon RG, Wener MH et al, 1997, J Urol, 157, 2183-90 | 9.6 | | Males | Non-healthy (excl pregnant) | Serum |
| Biological variation of prostate specific antigen levels In serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients, Nixon RG, Wener MH et al, 1997, J Urol, 157, 2183-90 | 7.7 | | Males | Non-healthy (excl pregnant) | Serum |
| Biological variation of prostate specific antigen levels In serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients, Nixon RG, Wener MH et al, 1997, J Urol, 157, 2183-90 | 8.6 | | Males | Non-healthy (excl pregnant) | Serum |
| Biological variation of total, free and percent free serumm protate specific antigen levels in screening volunteers, Ornstein DK, Smith DS et al, 1997, J Urol, 157, 2179-82 | 14.8 | | Males | Healthy (excl pregnant) | Serum |
| Biological variation of total, free and percent free serumm protate specific antigen levels in screening volunteers, Ornstein DK, Smith DS et al, 1997, J Urol, 157, 2179-82 | 15.6 | | Males | Healthy (excl pregnant) | Serum |
| Biological variation of total, free and percent free serumm protate specific antigen levels in screening volunteers, Ornstein DK, Smith DS et al, 1997, J Urol, 157, 2179-82 | 12.6 | | Males | Healthy (excl pregnant) | Serum |
| Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate càncer, Christensson A, Bruun L, Björk T et al, 2011, BJU Int, 107, 1769-74 | 4.0 | | Males | Non-healthy (excl pregnant) | Serum |
| Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate càncer, Christensson A, Bruun L, Björk T et al, 2011, BJU Int, 107, 1769-74 | 11.0 | | Males | Non-healthy (excl pregnant) | Serum |
| Day to day changes in free and total PSA: significance of biological variation, Nixon RG, Wener MH, Smith KM, Parson RE, Blase AB and Brawer MK, 1997, Prost Cancer and Prost diseas, 1, 90-6 | 7.3 | | Males | Non-healthy (excl pregnant) | Serum |
| Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies, Boddy JL, Dev A, Pike DJ and Malone PR, 2004, BJU International, 93(6), 735-8 | 5.7 | | Males | Non-healthy (excl pregnant) | Serum |
| Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies, Boddy JL, Dev A, Pike DJ and Malone PR, 2004, BJU International, 93(6), 735-8 | 9.7 | | Males | Non-healthy (excl pregnant) | Serum |
| Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies, Boddy JL, Dev A, Pike DJ and Malone PR, 2004, BJU International, 93(6), 735-8 | 14.1 | | Males | Non-healthy (excl pregnant) | Serum |
| Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies, Boddy JL, Dev A, Pike DJ and Malone PR, 2004, BJU International, 93(6), 735-8 | 10.6 | | Males | Non-healthy (excl pregnant) | Serum |
| Intra-individual variation of serum prostate specific antigen levels in men with benign prostate biopsies, Boddy JL, Dev A, Pike DJ and Malone PR, 2004, BJU International, 93(6), 735-8 | 12.0 | | Males | Non-healthy (excl pregnant) | Serum |
| Assessment of intra-individual variation in prostate-specific antigen levels in a biennal randomized prostate càncer screening program in Sweden, Bruun L, Becker Ch et al, 2005, Prostate, 65, 216-21 | 10.0 | | Males | Healthy (excl pregnant) | Serum |
